CH646057A5 - Mittel zur behandlung von glaucoma. - Google Patents
Mittel zur behandlung von glaucoma. Download PDFInfo
- Publication number
- CH646057A5 CH646057A5 CH22080A CH22080A CH646057A5 CH 646057 A5 CH646057 A5 CH 646057A5 CH 22080 A CH22080 A CH 22080A CH 22080 A CH22080 A CH 22080A CH 646057 A5 CH646057 A5 CH 646057A5
- Authority
- CH
- Switzerland
- Prior art keywords
- hydroxy
- propoxy
- dihydrocarbostyril
- compound
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54010108A JPS5951927B2 (ja) | 1979-01-30 | 1979-01-30 | 緑内障治療剤 |
JP54070361A JPS5951928B2 (ja) | 1979-06-04 | 1979-06-04 | 緑内障治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH646057A5 true CH646057A5 (de) | 1984-11-15 |
Family
ID=26345304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH22080A CH646057A5 (de) | 1979-01-30 | 1980-01-11 | Mittel zur behandlung von glaucoma. |
Country Status (15)
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0056420A1 (en) * | 1981-01-15 | 1982-07-28 | Schering Corporation | Ophthalmic gel |
FR2539413A1 (fr) * | 1983-01-17 | 1984-07-20 | Pos Lab | Carbostyriloximinopropanolamines utiles comme medicaments et procede pour leur preparation |
US4792561A (en) * | 1986-05-29 | 1988-12-20 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors |
US4921862A (en) * | 1986-05-29 | 1990-05-01 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors |
ES2070151T3 (es) * | 1988-08-10 | 1995-06-01 | Otsuka Pharma Co Ltd | Agentes cardiotonicos. |
US5198448A (en) * | 1988-08-10 | 1993-03-30 | Otsuka Pharmaceutical Company, Limited | Cardiotonics |
DK0389995T3 (da) * | 1989-03-28 | 1995-07-03 | Nisshin Flour Milling Co | Isoquinolinderivater til behandling af glaukom eller okular hypertension |
FR2676740B1 (fr) * | 1991-05-23 | 1993-11-05 | Roussel Uclaf | Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires. |
US5629345A (en) * | 1993-07-23 | 1997-05-13 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
US5965620A (en) * | 1993-07-23 | 1999-10-12 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
US5776482A (en) * | 1996-03-29 | 1998-07-07 | University Of Iowa Research Foundation | Tetrahydroquinoline analogues for use in glaucoma treatment |
MY116782A (en) | 1997-12-22 | 2004-03-31 | Otsuka Pharma Co Ltd | Water-soluble eye drop |
EP2117344A4 (en) * | 2006-12-06 | 2011-03-16 | United States Borax Inc | ANIMAL FEED |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3910924A (en) * | 1972-04-13 | 1975-10-07 | Otsuka Pharma Co Ltd | 3,4-Dihydrocarbostyril derivatives and a process for preparing the same |
JPS517672B2 (US20100268047A1-20101021-C00003.png) * | 1972-04-13 | 1976-03-10 | ||
AR207554A1 (es) * | 1972-12-02 | 1976-10-15 | Otsuka Pharma Co Ltd | Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2) |
JPS5239035B2 (US20100268047A1-20101021-C00003.png) * | 1972-12-14 | 1977-10-03 | ||
US3975391A (en) * | 1973-12-26 | 1976-08-17 | Otsuka Pharmaceutical Company Limited | 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives |
US3953546A (en) * | 1973-07-31 | 1976-04-27 | Sumitomo Chemical Company, Limited | Thio(dithio)phosphorates |
JPS5082218A (US20100268047A1-20101021-C00003.png) * | 1973-11-10 | 1975-07-03 | ||
US3994901A (en) * | 1974-06-13 | 1976-11-30 | Otsuka Pharmaceutical Company Limited | 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives |
US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
US4210753A (en) * | 1976-03-17 | 1980-07-01 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds |
CH619453A5 (US20100268047A1-20101021-C00003.png) * | 1976-03-17 | 1980-09-30 | Otsuka Pharma Co Ltd | |
DE2719562C2 (de) * | 1976-05-08 | 1986-05-07 | Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo | 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten |
JPS552631A (en) * | 1978-06-19 | 1980-01-10 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril derivative |
JPS5513241A (en) * | 1978-07-14 | 1980-01-30 | Otsuka Pharmaceut Co Ltd | Remedy for glaucoma |
-
1979
- 1979-12-28 AU AU54265/79A patent/AU518814B2/en not_active Expired
-
1980
- 1980-01-02 US US06/109,057 patent/US4309432A/en not_active Expired - Lifetime
- 1980-01-07 GB GB8000411A patent/GB2042338B/en not_active Expired
- 1980-01-09 IT IT05106/80A patent/IT1141662B/it active Protection Beyond IP Right Term
- 1980-01-10 DK DK11580A patent/DK11580A/da not_active Application Discontinuation
- 1980-01-11 FR FR8000552A patent/FR2447721A1/fr active Granted
- 1980-01-11 CA CA000343491A patent/CA1139669A/en not_active Expired
- 1980-01-11 SE SE8000245A patent/SE451069B/sv not_active IP Right Cessation
- 1980-01-11 CH CH22080A patent/CH646057A5/de not_active IP Right Cessation
- 1980-01-11 ES ES487642A patent/ES487642A0/es active Granted
- 1980-01-11 AT AT0014480A patent/AT371340B/de not_active IP Right Cessation
- 1980-01-11 NO NO800059A patent/NO800059L/no unknown
- 1980-01-11 FI FI800089A patent/FI800089A/fi not_active Application Discontinuation
- 1980-01-12 DE DE3001011A patent/DE3001011C2/de not_active Expired
- 1980-01-14 NL NL8000211A patent/NL191575C/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5426579A (en) | 1980-08-07 |
NL191575B (nl) | 1995-06-01 |
ATA14480A (de) | 1982-11-15 |
IT1141662B (it) | 1986-10-08 |
AU518814B2 (en) | 1981-10-22 |
GB2042338A (en) | 1980-09-24 |
FI800089A (fi) | 1980-07-31 |
AT371340B (de) | 1983-06-27 |
NL191575C (nl) | 1995-10-03 |
FR2447721A1 (fr) | 1980-08-29 |
DE3001011C2 (de) | 1986-02-06 |
DK11580A (da) | 1980-07-31 |
FR2447721B1 (US20100268047A1-20101021-C00003.png) | 1983-03-11 |
SE8000245L (sv) | 1980-07-31 |
IT8005106A0 (it) | 1980-01-09 |
DE3001011A1 (de) | 1980-08-28 |
GB2042338B (en) | 1983-11-30 |
NO800059L (no) | 1980-07-31 |
ES8100268A1 (es) | 1980-11-01 |
SE451069B (sv) | 1987-08-31 |
ES487642A0 (es) | 1980-11-01 |
NL8000211A (nl) | 1980-08-01 |
CA1139669A (en) | 1983-01-18 |
US4309432A (en) | 1982-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3788984T2 (de) | Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom. | |
DE68902649T2 (de) | Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen. | |
EP0242328B1 (de) | Arzneimittel zur Behandlung von Entzündungen im Auge | |
DE3507024C2 (de) | Lösung zur Augenbehandlung | |
DE2953723C2 (de) | Neue carbostyrilderivate, verfahren zu deren herstellung und diese enthaltende mittel | |
DE69634414T2 (de) | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie | |
DE68913650T2 (de) | Antiglaukoma-zubereitungen, die kombinationen von alpha-2 agonisten und beta-blocker enthalten. | |
EP0000133B1 (de) | Pharmazeutische Präparate mit einem Gehalt an sulfatierten Polysacchariden oder Polymeren und Zinkionen zur topischen Behandlung von Virusinfektionen. | |
US4127674A (en) | Method of treatment for glaucoma | |
DE68917071T2 (de) | Mittel zur stimulierung der tränensekretion. | |
CH646057A5 (de) | Mittel zur behandlung von glaucoma. | |
DE2523998A1 (de) | Pharmazeutische zubereitung fuer die behandlung der schizophrenie | |
DE69533723T2 (de) | Verwendung von chloridekanalblockern zur senkung des intraokulären druckes | |
DE69928806T2 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
DE69229688T4 (de) | Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten | |
DE69834638T2 (de) | Zusammensetzung zur Behandlung von Augenhypertension oder Glaukom | |
EP0585896A1 (de) | Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks | |
CH654205A5 (de) | Praeparat zur behandlung von glaucoma oder zur herabsetzung von intraocularem druck. | |
DE2460929C2 (US20100268047A1-20101021-C00003.png) | ||
DE2952959C2 (de) | Verwendung eines Carbostyrilderivats zur Behandlung von Glaucoma | |
DE60017174T2 (de) | Rivastigmine zur behandlung von augenerkrankungen | |
DE3248837T1 (de) | Zusammensetzungen fuer die behandlung von glaukom | |
DE69015919T2 (de) | 4-(2-Methyl-2-hydrooxypropylamino)-5,6-dihydrothieno-(2,3-B)thiopyran-2-sulfonamid-7,7-dioxid. | |
DE3688503T2 (de) | Erhöhung des ausfliessens wässriger körperfluessigkeit. | |
DE2532017C2 (de) | Ophthalmisches Mittel zur topischen Verabreichung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |